Sudden cardiac death: stratifying risk in dialysis patients

被引:0
作者
Rod Passman
Charles A. Herzog
机构
[1] Northwestern University Feinberg School of Medicine and the Bluhm Cardiovascular Institute,
[2] Cardiovascular Special Studies Center,undefined
[3] United States Renal Data System and Hennepin County Medical Center,undefined
[4] University of Minnesota,undefined
来源
Nature Reviews Nephrology | 2011年 / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Patients with end-stage renal disease have a heightened risk of cardiovascular morbidity and mortality. Cardiac arrest causes around one-quarter of deaths in this population, and a recent study has investigated whether echocardiographic parameters and serum biomarkers can be used to predict the risk of sudden cardiac death in patients on peritoneal dialysis.
引用
收藏
页码:133 / 135
页数:2
相关论文
共 8 条
[1]  
Wang AY(2010)Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis Hypertension 56 210-216
[2]  
Herzog CA(2008)Sudden cardiac death and dialysis patients Semin. Dial. 21 300-307
[3]  
Moss AJ(2002)Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N. Engl. J. Med. 346 877-883
[4]  
Bardy GH(2005)Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N. Engl. J. Med. 352 225-237
[5]  
Apple FS(2002)Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease Circulation 106 2941-2945
[6]  
Myerburg RJ(1998)Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact Circulation 97 1514-1521
[7]  
Cice G(2003)Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial J. Am. Coll. Cardiol. 41 1438-1444
[8]  
Epstein AE(2008)ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons J. Am. Coll. Cardiol. 51 1-62